WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew D. DickinsonChief Financial Officer2025-09-152,500$113.57
$283.93kSell
Johanna MercierChief Commercial Officer2025-09-153,000$113.57
$340.71kSell
Johanna MercierChief Commercial Officer2025-09-101,819$115.25
$209.64kSell
Daniel Patrick OdayChairman CEO2025-09-104,949$115.25
$570.37kSell
Deborah H. TelmanEVP Corporate Affairs GC2025-09-10634$115.25
$73.07kSell
Diane E. WilfongInterim Corp Controller CAO2025-09-10338$115.25
$38.95kSell
Andrew D. DickinsonChief Financial Officer2025-09-101,751$115.25
$201.80kSell
Daniel Patrick OdayChairman CEO2025-08-2810,000$113.63
$1.14MSell
Johanna MercierChief Commercial Officer2025-08-15700$66.64
$46.65kBuy
Johanna MercierChief Commercial Officer2025-08-152,800$118.51
$331.82kSell

1 of 11

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.62%119,364,226$13.23BInstitution
Blackrock Inc9.26%114,879,922$12.74BInstitution
Fmr LLC4.83%59,955,377$6.65BInstitution
State Street Corp4.77%59,188,160$6.56BInstitution
Capital World Investors3.73%46,303,299$5.13BInstitution
Wellington Management Group LLP3.02%37,530,510$4.16BInstitution
Capital Research Global Investors2.51%31,097,679$3.45BInstitution
Dodge Cox2.48%30,818,322$3.42BInstitution
Geode Capital Management LLC2.35%29,207,662$3.24BInstitution
Price T Rowe Associates Inc1.90%23,586,692$2.61BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD86.34%1.11%Net SellingNet Selling
PFE65.25%0.27%Net Buying
AMGN81.21%0.99%Net SellingNet Selling
SNY19.39%0.00%
BMY80.35%0.36%Net SellingNet Selling
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 86.34% institutional shareholders, 1.11% Gilead Sciences insiders, and 12.55% retail investors. Vanguard Group Inc is the largest individual Gilead Sciences shareholder, owning 119.36M shares representing 9.62% of the company. Vanguard Group Inc's Gilead Sciences shares are currently valued at $13.40B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.